You are here: Home » News-CM » Companies » Results
Business Standard

Sterling Biotech reports standalone net profit of Rs 36.97 crore in the December 2018 quarter

Capital Market 

Sales rise 8.38% to Rs 94.95 crore

Net profit of reported to Rs 36.97 crore in the quarter ended December 2018 as against net loss of Rs 168.02 crore during the previous quarter ended December 2017. Sales rose 8.38% to Rs 94.95 crore in the quarter ended December 2018 as against Rs 87.61 crore during the previous quarter ended December 2017. ParticularsQuarter EndedDec. 2018Dec. 2017% Var.Sales94.9587.61 8 OPM %11.944.43 -PBDT114.35-106.58 LP PBT52.88-168.02 LP NP36.97-168.02 LP

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, February 11 2019. 17:12 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU